Jefferies raises ArriVent Biopharma target price to $27 from $18
AVBP•Jefferies raised its target price for ArriVent Biopharma to $27 from $18.
Related News
ACCO Brands publishes update to financial calendar
ACCO•
AI jitters, Trump's fading oil clout and China shock 2.0: The financial week in five charts
SPY•
Poet Technologies publishes update to financial calendar
POET•
Travelers year-to-date 2026 net income jumps 54% to $5.84 billion
TRV•
The Gap, Inc.: Needham initiates coverage with hold rating
GAP•